The effect of basal–bolus therapy varies with baseline 1,5‐anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis

por Heller, S., Bowering, K., Raskin, P., Liebl, A., Buchholtz, K., Gorst‐Rasmussen, A., Pieber, T. R.
Publicado 2018